| Grace Cottage Hospital | |
| Po Box 216, Townshend, Vermont 05353 | |
| (802) 365-7920 | |
| Not Available |
| Name | Grace Cottage Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | Po Box 216, Townshend, Vermont |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 471300 |
| NPI Number | 1255337473 |
| Organization Name | CARLOS G. OTIS HEALTH CARE CENTER INC. |
| Doing Business As | GRACE COTTAGE HOSPITAL |
| Address | 185 Grafton Rd, Townshend, VT 05353 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 802-365-7920 |
News Archive
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010.
In experiments with mice, a team of scientists from the United States, Sweden and Japan has discovered that having a double dose of one protein is sufficient to change the normal balance of cells within the lining of the colon, thereby doubling the risk that a cancer-causing genetic mutation will trigger a tumor there.
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
› Verified 7 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010.
In experiments with mice, a team of scientists from the United States, Sweden and Japan has discovered that having a double dose of one protein is sufficient to change the normal balance of cells within the lining of the colon, thereby doubling the risk that a cancer-causing genetic mutation will trigger a tumor there.
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
› Verified 7 days ago
Grace Cottage Hospital Critical Access Hospital Location: Po Box 216, Townshend, Vermont 05353 Phone: (802) 365-7920 |